16.01.2026
Deal: Wenger Vieli advised the shareholders of TOFWERK on its sale to Bruker
10.11.2025
Deal: Wenger Vieli advised arcoris bio on its CHF 6.3m seed financing round
24.10.2025
Deal: Wenger Vieli advised QUMEA on GRO’s strategic investment
30.09.2025
Deal: Wenger Vieli advised Corintis on its USD 24m Series A financing round
05.09.2025
Deal: Wenger Vieli supported 3i on the sale of its participation in MAIT
26.08.2025
Deal: Wenger Vieli advised Frutiger on its participation in Blumer Lehmann
19.08.2025
Deal: Wenger Vieli acted as lead counsel to Verdane
07.02.2025
Deal: Wenger Vieli advised Jakob Müller Holding on the acquisition of Buss Group
08.07.2024
Deal: Wenger Vieli advised the shareholders of 42matters on the acquisition by Similarweb
27.05.2024
Deal: Wenger Vieli advised the shareholders of Alturos on the sale to Juniper Group
22.05.2024
Deal: Wenger Vieli advised Mobil in Time in the acquisition of Bilfit
18.03.2024
Deal: Wenger Vieli advised Basellandschaftliche Kantonalbank on obtaining a licence as fund manage-ment company for its subsidiary
08.03.2024
Deal: Wenger Vieli Advised the Shareholders of Locatee on its Sale to Tango
07.03.2024
Deal: Wenger Vieli Advised redalpine on its Investment in dropz
30.01.2024
Deal: Wenger Vieli advised investors represented by Verium on the acquisition of a stake in Impact Acoustic
29.01.2024
Deal: Wenger Vieli advised the shareholders of Anavia on the sale of a stake to the EDGE Group PJSC
15.01.2024
Deal: Wenger Vieli advised SWISS KRONO Group in the acquisition of Argolite
22.12.2023
Deal: Wenger Vieli advised the shareholders of Isovalent Inc. on its sale to Cisco
20.09.2023
Deal: Wenger Vieli advised sell-side in the sale transaction of EXALOS to indie Semiconductor
31.07.2023
Deal: IK Partners sells Klingel Medical Group to Elos Medtech AB
31.03.2023
Deal: Shop Apotheke Europe and Galenica enter into strategic partnership
15.11.2022
Wenger Vieli advised the lead investor Redalpine Opportunity Fund on the closing of Carvolution's Series D Financing Round
10.03.2022
Deal: Acquisition of Artmyn by Invaluable
05.10.2021
Deal: Sale of TestingTime Group to Norstat AS
13.08.2021
Deal: Advisor to Atlas Antibodies